Synopsis of recent research by authors named "Erik de Graaf"
- Erik de Graaf's recent research focuses on the role of kinase activity and glycosylation in cancer treatment and immune responses, particularly in diseases like HER2-positive breast cancer and fetal and neonatal alloimmune thrombocytopenia.
- His studies have developed innovative strategies for measuring kinase activities and highlighted the complexity of IgG glycosylation and its effects on both therapeutic responses and immune interactions.
- De Graaf's findings reveal significant variability in treatment outcomes linked to patient-specific factors and model systems, advancing the understanding of treatment resistance in glioblastoma and implications for antibody efficacy in various diseases.
